line_item,period,value,symbol
Tax Effect Of Unusual Items,2025-03-31 00:00:00,-192642237.448078,ULTRACEMCO.NS
Tax Rate For Calcs,2025-03-31 00:00:00,0.197724,ULTRACEMCO.NS
Normalized EBITDA,2025-03-31 00:00:00,132910500000.0,ULTRACEMCO.NS
Total Unusual Items,2025-03-31 00:00:00,-974300000.0,ULTRACEMCO.NS
Total Unusual Items Excluding Goodwill,2025-03-31 00:00:00,-974300000.0,ULTRACEMCO.NS
Net Income From Continuing Operation Net Minority Interest,2025-03-31 00:00:00,60391100000.0,ULTRACEMCO.NS
Reconciled Depreciation,2025-03-31 00:00:00,40148500000.0,ULTRACEMCO.NS
Reconciled Cost Of Revenue,2025-03-31 00:00:00,137037300000.0,ULTRACEMCO.NS
EBITDA,2025-03-31 00:00:00,131936200000.0,ULTRACEMCO.NS
EBIT,2025-03-31 00:00:00,91786700000.0,ULTRACEMCO.NS
Net Interest Income,2025-03-31 00:00:00,-16505400000.0,ULTRACEMCO.NS
Interest Expense,2025-03-31 00:00:00,16505400000.0,ULTRACEMCO.NS
Interest Income,2025-03-31 00:00:00,,ULTRACEMCO.NS
Normalized Income,2025-03-31 00:00:00,61172757762.551926,ULTRACEMCO.NS
Net Income From Continuing And Discontinued Operation,2025-03-31 00:00:00,60391100000.0,ULTRACEMCO.NS
Total Expenses,2025-03-31 00:00:00,674126300000.0,ULTRACEMCO.NS
Rent Expense Supplemental,2025-03-31 00:00:00,,ULTRACEMCO.NS
Diluted Average Shares,2025-03-31 00:00:00,,ULTRACEMCO.NS
Basic Average Shares,2025-03-31 00:00:00,,ULTRACEMCO.NS
Diluted EPS,2025-03-31 00:00:00,,ULTRACEMCO.NS
Basic EPS,2025-03-31 00:00:00,,ULTRACEMCO.NS
Diluted NI Availto Com Stockholders,2025-03-31 00:00:00,60391100000.0,ULTRACEMCO.NS
Net Income Common Stockholders,2025-03-31 00:00:00,60391100000.0,ULTRACEMCO.NS
Otherunder Preferred Stock Dividend,2025-03-31 00:00:00,0.0,ULTRACEMCO.NS
Net Income,2025-03-31 00:00:00,60391100000.0,ULTRACEMCO.NS
Minority Interests,2025-03-31 00:00:00,-5300000.0,ULTRACEMCO.NS
Net Income Including Noncontrolling Interests,2025-03-31 00:00:00,60396400000.0,ULTRACEMCO.NS
Net Income Discontinuous Operations,2025-03-31 00:00:00,,ULTRACEMCO.NS
Net Income Continuous Operations,2025-03-31 00:00:00,60396400000.0,ULTRACEMCO.NS
Tax Provision,2025-03-31 00:00:00,14884900000.0,ULTRACEMCO.NS
Pretax Income,2025-03-31 00:00:00,75281300000.0,ULTRACEMCO.NS
Other Non Operating Income Expenses,2025-03-31 00:00:00,7441700000.0,ULTRACEMCO.NS
Special Income Charges,2025-03-31 00:00:00,-974300000.0,ULTRACEMCO.NS
Other Special Charges,2025-03-31 00:00:00,,ULTRACEMCO.NS
Write Off,2025-03-31 00:00:00,93500000.0,ULTRACEMCO.NS
Restructuring And Mergern Acquisition,2025-03-31 00:00:00,880800000.0,ULTRACEMCO.NS
Net Non Operating Interest Income Expense,2025-03-31 00:00:00,-16505400000.0,ULTRACEMCO.NS
Total Other Finance Cost,2025-03-31 00:00:00,,ULTRACEMCO.NS
Interest Expense Non Operating,2025-03-31 00:00:00,16505400000.0,ULTRACEMCO.NS
Interest Income Non Operating,2025-03-31 00:00:00,,ULTRACEMCO.NS
Operating Income,2025-03-31 00:00:00,85425000000.0,ULTRACEMCO.NS
Operating Expense,2025-03-31 00:00:00,537089000000.0,ULTRACEMCO.NS
Other Operating Expenses,2025-03-31 00:00:00,286295300000.0,ULTRACEMCO.NS
Depreciation And Amortization In Income Statement,2025-03-31 00:00:00,40149500000.0,ULTRACEMCO.NS
Amortization,2025-03-31 00:00:00,,ULTRACEMCO.NS
Depreciation Income Statement,2025-03-31 00:00:00,40149500000.0,ULTRACEMCO.NS
Selling General And Administration,2025-03-31 00:00:00,174598300000.0,ULTRACEMCO.NS
Selling And Marketing Expense,2025-03-31 00:00:00,174598300000.0,ULTRACEMCO.NS
General And Administrative Expense,2025-03-31 00:00:00,,ULTRACEMCO.NS
Rent And Landing Fees,2025-03-31 00:00:00,,ULTRACEMCO.NS
Gross Profit,2025-03-31 00:00:00,622514000000.0,ULTRACEMCO.NS
Cost Of Revenue,2025-03-31 00:00:00,137037300000.0,ULTRACEMCO.NS
Total Revenue,2025-03-31 00:00:00,759551300000.0,ULTRACEMCO.NS
Operating Revenue,2025-03-31 00:00:00,759551300000.0,ULTRACEMCO.NS
Tax Effect Of Unusual Items,2024-03-31 00:00:00,-184791609.620663,ULTRACEMCO.NS
Tax Rate For Calcs,2024-03-31 00:00:00,0.256655,ULTRACEMCO.NS
Normalized EBITDA,2024-03-31 00:00:00,136075200000.0,ULTRACEMCO.NS
Total Unusual Items,2024-03-31 00:00:00,-720000000.0,ULTRACEMCO.NS
Total Unusual Items Excluding Goodwill,2024-03-31 00:00:00,-720000000.0,ULTRACEMCO.NS
Net Income From Continuing Operation Net Minority Interest,2024-03-31 00:00:00,70050000000.0,ULTRACEMCO.NS
Reconciled Depreciation,2024-03-31 00:00:00,31453000000.0,ULTRACEMCO.NS
Reconciled Cost Of Revenue,2024-03-31 00:00:00,119029200000.0,ULTRACEMCO.NS
EBITDA,2024-03-31 00:00:00,135355200000.0,ULTRACEMCO.NS
EBIT,2024-03-31 00:00:00,103902200000.0,ULTRACEMCO.NS
Net Interest Income,2024-03-31 00:00:00,-9680000000.0,ULTRACEMCO.NS
Interest Expense,2024-03-31 00:00:00,9680000000.0,ULTRACEMCO.NS
Interest Income,2024-03-31 00:00:00,2407500000.0,ULTRACEMCO.NS
Normalized Income,2024-03-31 00:00:00,70585208390.37933,ULTRACEMCO.NS
Net Income From Continuing And Discontinued Operation,2024-03-31 00:00:00,70050000000.0,ULTRACEMCO.NS
Total Expenses,2024-03-31 00:00:00,610848800000.0,ULTRACEMCO.NS
Rent Expense Supplemental,2024-03-31 00:00:00,1723900000.0,ULTRACEMCO.NS
Diluted Average Shares,2024-03-31 00:00:00,288425907.0,ULTRACEMCO.NS
Basic Average Shares,2024-03-31 00:00:00,288212302.0,ULTRACEMCO.NS
Diluted EPS,2024-03-31 00:00:00,242.87,ULTRACEMCO.NS
Basic EPS,2024-03-31 00:00:00,243.05,ULTRACEMCO.NS
Diluted NI Availto Com Stockholders,2024-03-31 00:00:00,70050000000.0,ULTRACEMCO.NS
Net Income Common Stockholders,2024-03-31 00:00:00,70050000000.0,ULTRACEMCO.NS
Otherunder Preferred Stock Dividend,2024-03-31 00:00:00,0.0,ULTRACEMCO.NS
Net Income,2024-03-31 00:00:00,70050000000.0,ULTRACEMCO.NS
Minority Interests,2024-03-31 00:00:00,10400000.0,ULTRACEMCO.NS
Net Income Including Noncontrolling Interests,2024-03-31 00:00:00,70039600000.0,ULTRACEMCO.NS
Net Income Discontinuous Operations,2024-03-31 00:00:00,,ULTRACEMCO.NS
Net Income Continuous Operations,2024-03-31 00:00:00,70039600000.0,ULTRACEMCO.NS
Tax Provision,2024-03-31 00:00:00,24182600000.0,ULTRACEMCO.NS
Pretax Income,2024-03-31 00:00:00,94222200000.0,ULTRACEMCO.NS
Other Non Operating Income Expenses,2024-03-31 00:00:00,6169500000.0,ULTRACEMCO.NS
Special Income Charges,2024-03-31 00:00:00,-720000000.0,ULTRACEMCO.NS
Other Special Charges,2024-03-31 00:00:00,-585900000.0,ULTRACEMCO.NS
Write Off,2024-03-31 00:00:00,0.0,ULTRACEMCO.NS
Restructuring And Mergern Acquisition,2024-03-31 00:00:00,720000000.0,ULTRACEMCO.NS
Net Non Operating Interest Income Expense,2024-03-31 00:00:00,-9680000000.0,ULTRACEMCO.NS
Total Other Finance Cost,2024-03-31 00:00:00,39000000.0,ULTRACEMCO.NS
Interest Expense Non Operating,2024-03-31 00:00:00,9680000000.0,ULTRACEMCO.NS
Interest Income Non Operating,2024-03-31 00:00:00,2407500000.0,ULTRACEMCO.NS
Operating Income,2024-03-31 00:00:00,98232600000.0,ULTRACEMCO.NS
Operating Expense,2024-03-31 00:00:00,491819600000.0,ULTRACEMCO.NS
Other Operating Expenses,2024-03-31 00:00:00,271184100000.0,ULTRACEMCO.NS
Depreciation And Amortization In Income Statement,2024-03-31 00:00:00,31453000000.0,ULTRACEMCO.NS
Amortization,2024-03-31 00:00:00,1983100000.0,ULTRACEMCO.NS
Depreciation Income Statement,2024-03-31 00:00:00,31453000000.0,ULTRACEMCO.NS
Selling General And Administration,2024-03-31 00:00:00,158806700000.0,ULTRACEMCO.NS
Selling And Marketing Expense,2024-03-31 00:00:00,158806700000.0,ULTRACEMCO.NS
General And Administrative Expense,2024-03-31 00:00:00,1819300000.0,ULTRACEMCO.NS
Rent And Landing Fees,2024-03-31 00:00:00,1723900000.0,ULTRACEMCO.NS
Gross Profit,2024-03-31 00:00:00,590052200000.0,ULTRACEMCO.NS
Cost Of Revenue,2024-03-31 00:00:00,119029200000.0,ULTRACEMCO.NS
Total Revenue,2024-03-31 00:00:00,709081400000.0,ULTRACEMCO.NS
Operating Revenue,2024-03-31 00:00:00,709081400000.0,ULTRACEMCO.NS
Tax Effect Of Unusual Items,2023-03-31 00:00:00,412091550.0,ULTRACEMCO.NS
Tax Rate For Calcs,2023-03-31 00:00:00,0.3159,ULTRACEMCO.NS
Normalized EBITDA,2023-03-31 00:00:00,109357400000.0,ULTRACEMCO.NS
Total Unusual Items,2023-03-31 00:00:00,1304500000.0,ULTRACEMCO.NS
Total Unusual Items Excluding Goodwill,2023-03-31 00:00:00,1304500000.0,ULTRACEMCO.NS
Net Income From Continuing Operation Net Minority Interest,2023-03-31 00:00:00,50639600000.0,ULTRACEMCO.NS
Reconciled Depreciation,2023-03-31 00:00:00,28879900000.0,ULTRACEMCO.NS
Reconciled Cost Of Revenue,2023-03-31 00:00:00,109045900000.0,ULTRACEMCO.NS
EBITDA,2023-03-31 00:00:00,110661900000.0,ULTRACEMCO.NS
EBIT,2023-03-31 00:00:00,81782000000.0,ULTRACEMCO.NS
Net Interest Income,2023-03-31 00:00:00,-4957300000.0,ULTRACEMCO.NS
Interest Expense,2023-03-31 00:00:00,7619500000.0,ULTRACEMCO.NS
Interest Income,2023-03-31 00:00:00,2724500000.0,ULTRACEMCO.NS
Normalized Income,2023-03-31 00:00:00,49747191550.0,ULTRACEMCO.NS
Net Income From Continuing And Discontinued Operation,2023-03-31 00:00:00,50639600000.0,ULTRACEMCO.NS
Total Expenses,2023-03-31 00:00:00,547604500000.0,ULTRACEMCO.NS
Rent Expense Supplemental,2023-03-31 00:00:00,1944100000.0,ULTRACEMCO.NS
Diluted Average Shares,2023-03-31 00:00:00,288480570.0,ULTRACEMCO.NS
Basic Average Shares,2023-03-31 00:00:00,288326723.0,ULTRACEMCO.NS
Diluted EPS,2023-03-31 00:00:00,175.54,ULTRACEMCO.NS
Basic EPS,2023-03-31 00:00:00,175.63,ULTRACEMCO.NS
Diluted NI Availto Com Stockholders,2023-03-31 00:00:00,50639600000.0,ULTRACEMCO.NS
Net Income Common Stockholders,2023-03-31 00:00:00,50639600000.0,ULTRACEMCO.NS
Otherunder Preferred Stock Dividend,2023-03-31 00:00:00,0.0,ULTRACEMCO.NS
Net Income,2023-03-31 00:00:00,50639600000.0,ULTRACEMCO.NS
Minority Interests,2023-03-31 00:00:00,-94400000.0,ULTRACEMCO.NS
Net Income Including Noncontrolling Interests,2023-03-31 00:00:00,50734000000.0,ULTRACEMCO.NS
Net Income Discontinuous Operations,2023-03-31 00:00:00,0.0,ULTRACEMCO.NS
Net Income Continuous Operations,2023-03-31 00:00:00,50734000000.0,ULTRACEMCO.NS
Tax Provision,2023-03-31 00:00:00,23428500000.0,ULTRACEMCO.NS
Pretax Income,2023-03-31 00:00:00,74162500000.0,ULTRACEMCO.NS
Other Non Operating Income Expenses,2023-03-31 00:00:00,1497200000.0,ULTRACEMCO.NS
Special Income Charges,2023-03-31 00:00:00,328300000.0,ULTRACEMCO.NS
Other Special Charges,2023-03-31 00:00:00,-328300000.0,ULTRACEMCO.NS
Write Off,2023-03-31 00:00:00,,ULTRACEMCO.NS
Restructuring And Mergern Acquisition,2023-03-31 00:00:00,0.0,ULTRACEMCO.NS
Net Non Operating Interest Income Expense,2023-03-31 00:00:00,-4957300000.0,ULTRACEMCO.NS
Total Other Finance Cost,2023-03-31 00:00:00,62300000.0,ULTRACEMCO.NS
Interest Expense Non Operating,2023-03-31 00:00:00,7619500000.0,ULTRACEMCO.NS
Interest Income Non Operating,2023-03-31 00:00:00,2724500000.0,ULTRACEMCO.NS
Operating Income,2023-03-31 00:00:00,75771500000.0,ULTRACEMCO.NS
Operating Expense,2023-03-31 00:00:00,438558600000.0,ULTRACEMCO.NS
Other Operating Expenses,2023-03-31 00:00:00,213715200000.0,ULTRACEMCO.NS
Depreciation And Amortization In Income Statement,2023-03-31 00:00:00,28879900000.0,ULTRACEMCO.NS
Amortization,2023-03-31 00:00:00,1949200000.0,ULTRACEMCO.NS
Depreciation Income Statement,2023-03-31 00:00:00,26930700000.0,ULTRACEMCO.NS
Selling General And Administration,2023-03-31 00:00:00,174017500000.0,ULTRACEMCO.NS
Selling And Marketing Expense,2023-03-31 00:00:00,172279100000.0,ULTRACEMCO.NS
General And Administrative Expense,2023-03-31 00:00:00,1738400000.0,ULTRACEMCO.NS
Rent And Landing Fees,2023-03-31 00:00:00,1944100000.0,ULTRACEMCO.NS
Gross Profit,2023-03-31 00:00:00,514330100000.0,ULTRACEMCO.NS
Cost Of Revenue,2023-03-31 00:00:00,109045900000.0,ULTRACEMCO.NS
Total Revenue,2023-03-31 00:00:00,623376000000.0,ULTRACEMCO.NS
Operating Revenue,2023-03-31 00:00:00,623376000000.0,ULTRACEMCO.NS
Tax Effect Of Unusual Items,2022-03-31 00:00:00,472348230.0,ULTRACEMCO.NS
Tax Rate For Calcs,2022-03-31 00:00:00,0.1479,ULTRACEMCO.NS
Normalized EBITDA,2022-03-31 00:00:00,116454700000.0,ULTRACEMCO.NS
Total Unusual Items,2022-03-31 00:00:00,3193700000.0,ULTRACEMCO.NS
Total Unusual Items Excluding Goodwill,2022-03-31 00:00:00,3193700000.0,ULTRACEMCO.NS
Net Income From Continuing Operation Net Minority Interest,2022-03-31 00:00:00,71843900000.0,ULTRACEMCO.NS
Reconciled Depreciation,2022-03-31 00:00:00,27147500000.0,ULTRACEMCO.NS
Reconciled Cost Of Revenue,2022-03-31 00:00:00,89982100000.0,ULTRACEMCO.NS
EBITDA,2022-03-31 00:00:00,119648400000.0,ULTRACEMCO.NS
EBIT,2022-03-31 00:00:00,92500900000.0,ULTRACEMCO.NS
Net Interest Income,2022-03-31 00:00:00,-7354500000.0,ULTRACEMCO.NS
Interest Expense,2022-03-31 00:00:00,8856900000.0,ULTRACEMCO.NS
Interest Income,2022-03-31 00:00:00,1637000000.0,ULTRACEMCO.NS
Normalized Income,2022-03-31 00:00:00,69122548230.0,ULTRACEMCO.NS
Net Income From Continuing And Discontinued Operation,2022-03-31 00:00:00,73443100000.0,ULTRACEMCO.NS
Total Expenses,2022-03-31 00:00:00,428710400000.0,ULTRACEMCO.NS
Rent Expense Supplemental,2022-03-31 00:00:00,1546100000.0,ULTRACEMCO.NS
Diluted Average Shares,2022-03-31 00:00:00,288547584.0,ULTRACEMCO.NS
Basic Average Shares,2022-03-31 00:00:00,288424921.0,ULTRACEMCO.NS
Diluted EPS,2022-03-31 00:00:00,254.53,ULTRACEMCO.NS
Basic EPS,2022-03-31 00:00:00,254.64,ULTRACEMCO.NS
Diluted NI Availto Com Stockholders,2022-03-31 00:00:00,73443100000.0,ULTRACEMCO.NS
Net Income Common Stockholders,2022-03-31 00:00:00,73443100000.0,ULTRACEMCO.NS
Otherunder Preferred Stock Dividend,2022-03-31 00:00:00,0.0,ULTRACEMCO.NS
Net Income,2022-03-31 00:00:00,73443100000.0,ULTRACEMCO.NS
Minority Interests,2022-03-31 00:00:00,100500000.0,ULTRACEMCO.NS
Net Income Including Noncontrolling Interests,2022-03-31 00:00:00,73342600000.0,ULTRACEMCO.NS
Net Income Discontinuous Operations,2022-03-31 00:00:00,1599200000.0,ULTRACEMCO.NS
Net Income Continuous Operations,2022-03-31 00:00:00,71743400000.0,ULTRACEMCO.NS
Tax Provision,2022-03-31 00:00:00,11900600000.0,ULTRACEMCO.NS
Pretax Income,2022-03-31 00:00:00,83644000000.0,ULTRACEMCO.NS
Other Non Operating Income Expenses,2022-03-31 00:00:00,523000000.0,ULTRACEMCO.NS
Special Income Charges,2022-03-31 00:00:00,305500000.0,ULTRACEMCO.NS
Other Special Charges,2022-03-31 00:00:00,-305500000.0,ULTRACEMCO.NS
Write Off,2022-03-31 00:00:00,0.0,ULTRACEMCO.NS
Restructuring And Mergern Acquisition,2022-03-31 00:00:00,,ULTRACEMCO.NS
Net Non Operating Interest Income Expense,2022-03-31 00:00:00,-7354500000.0,ULTRACEMCO.NS
Total Other Finance Cost,2022-03-31 00:00:00,134600000.0,ULTRACEMCO.NS
Interest Expense Non Operating,2022-03-31 00:00:00,8856900000.0,ULTRACEMCO.NS
Interest Income Non Operating,2022-03-31 00:00:00,1637000000.0,ULTRACEMCO.NS
Operating Income,2022-03-31 00:00:00,88368100000.0,ULTRACEMCO.NS
Operating Expense,2022-03-31 00:00:00,338728300000.0,ULTRACEMCO.NS
Other Operating Expenses,2022-03-31 00:00:00,145626500000.0,ULTRACEMCO.NS
Depreciation And Amortization In Income Statement,2022-03-31 00:00:00,27147500000.0,ULTRACEMCO.NS
Amortization,2022-03-31 00:00:00,1727100000.0,ULTRACEMCO.NS
Depreciation Income Statement,2022-03-31 00:00:00,25420400000.0,ULTRACEMCO.NS
Selling General And Administration,2022-03-31 00:00:00,147578400000.0,ULTRACEMCO.NS
Selling And Marketing Expense,2022-03-31 00:00:00,146291100000.0,ULTRACEMCO.NS
General And Administrative Expense,2022-03-31 00:00:00,1287300000.0,ULTRACEMCO.NS
Rent And Landing Fees,2022-03-31 00:00:00,1546100000.0,ULTRACEMCO.NS
Gross Profit,2022-03-31 00:00:00,427096400000.0,ULTRACEMCO.NS
Cost Of Revenue,2022-03-31 00:00:00,89982100000.0,ULTRACEMCO.NS
Total Revenue,2022-03-31 00:00:00,517078500000.0,ULTRACEMCO.NS
Operating Revenue,2022-03-31 00:00:00,517078500000.0,ULTRACEMCO.NS
Tax Effect Of Unusual Items,2021-03-31 00:00:00,,ULTRACEMCO.NS
Tax Rate For Calcs,2021-03-31 00:00:00,,ULTRACEMCO.NS
Normalized EBITDA,2021-03-31 00:00:00,,ULTRACEMCO.NS
Total Unusual Items,2021-03-31 00:00:00,,ULTRACEMCO.NS
Total Unusual Items Excluding Goodwill,2021-03-31 00:00:00,,ULTRACEMCO.NS
Net Income From Continuing Operation Net Minority Interest,2021-03-31 00:00:00,,ULTRACEMCO.NS
Reconciled Depreciation,2021-03-31 00:00:00,,ULTRACEMCO.NS
Reconciled Cost Of Revenue,2021-03-31 00:00:00,,ULTRACEMCO.NS
EBITDA,2021-03-31 00:00:00,,ULTRACEMCO.NS
EBIT,2021-03-31 00:00:00,,ULTRACEMCO.NS
Net Interest Income,2021-03-31 00:00:00,,ULTRACEMCO.NS
Interest Expense,2021-03-31 00:00:00,,ULTRACEMCO.NS
Interest Income,2021-03-31 00:00:00,1007600000.0,ULTRACEMCO.NS
Normalized Income,2021-03-31 00:00:00,,ULTRACEMCO.NS
Net Income From Continuing And Discontinued Operation,2021-03-31 00:00:00,,ULTRACEMCO.NS
Total Expenses,2021-03-31 00:00:00,,ULTRACEMCO.NS
Rent Expense Supplemental,2021-03-31 00:00:00,1273900000.0,ULTRACEMCO.NS
Diluted Average Shares,2021-03-31 00:00:00,288552537.0,ULTRACEMCO.NS
Basic Average Shares,2021-03-31 00:00:00,288448714.0,ULTRACEMCO.NS
Diluted EPS,2021-03-31 00:00:00,189.33,ULTRACEMCO.NS
Basic EPS,2021-03-31 00:00:00,189.4,ULTRACEMCO.NS
Diluted NI Availto Com Stockholders,2021-03-31 00:00:00,,ULTRACEMCO.NS
Net Income Common Stockholders,2021-03-31 00:00:00,,ULTRACEMCO.NS
Otherunder Preferred Stock Dividend,2021-03-31 00:00:00,,ULTRACEMCO.NS
Net Income,2021-03-31 00:00:00,,ULTRACEMCO.NS
Minority Interests,2021-03-31 00:00:00,,ULTRACEMCO.NS
Net Income Including Noncontrolling Interests,2021-03-31 00:00:00,,ULTRACEMCO.NS
Net Income Discontinuous Operations,2021-03-31 00:00:00,1429100000.0,ULTRACEMCO.NS
Net Income Continuous Operations,2021-03-31 00:00:00,,ULTRACEMCO.NS
Tax Provision,2021-03-31 00:00:00,,ULTRACEMCO.NS
Pretax Income,2021-03-31 00:00:00,,ULTRACEMCO.NS
Other Non Operating Income Expenses,2021-03-31 00:00:00,,ULTRACEMCO.NS
Special Income Charges,2021-03-31 00:00:00,,ULTRACEMCO.NS
Other Special Charges,2021-03-31 00:00:00,1364400000.0,ULTRACEMCO.NS
Write Off,2021-03-31 00:00:00,967400000.0,ULTRACEMCO.NS
Restructuring And Mergern Acquisition,2021-03-31 00:00:00,,ULTRACEMCO.NS
Net Non Operating Interest Income Expense,2021-03-31 00:00:00,,ULTRACEMCO.NS
Total Other Finance Cost,2021-03-31 00:00:00,51300000.0,ULTRACEMCO.NS
Interest Expense Non Operating,2021-03-31 00:00:00,,ULTRACEMCO.NS
Interest Income Non Operating,2021-03-31 00:00:00,1007600000.0,ULTRACEMCO.NS
Operating Income,2021-03-31 00:00:00,,ULTRACEMCO.NS
Operating Expense,2021-03-31 00:00:00,,ULTRACEMCO.NS
Other Operating Expenses,2021-03-31 00:00:00,,ULTRACEMCO.NS
Depreciation And Amortization In Income Statement,2021-03-31 00:00:00,,ULTRACEMCO.NS
Amortization,2021-03-31 00:00:00,1517800000.0,ULTRACEMCO.NS
Depreciation Income Statement,2021-03-31 00:00:00,,ULTRACEMCO.NS
Selling General And Administration,2021-03-31 00:00:00,,ULTRACEMCO.NS
Selling And Marketing Expense,2021-03-31 00:00:00,,ULTRACEMCO.NS
General And Administrative Expense,2021-03-31 00:00:00,1222400000.0,ULTRACEMCO.NS
Rent And Landing Fees,2021-03-31 00:00:00,1273900000.0,ULTRACEMCO.NS
Gross Profit,2021-03-31 00:00:00,,ULTRACEMCO.NS
Cost Of Revenue,2021-03-31 00:00:00,,ULTRACEMCO.NS
Total Revenue,2021-03-31 00:00:00,,ULTRACEMCO.NS
Operating Revenue,2021-03-31 00:00:00,,ULTRACEMCO.NS
